Apogee Therapeutics, Inc. APGE Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$74.11M-6.8% | -$69.39M-6.7% | -$65.02M+1.6% | -$66.1M-19.4% | -$55.34M+17.7% | ||
| $408K+0.5% | $406K+1.5% | $400K0.0% | $400K+93.2% | $207K+172% | ||
| $17.16M+43.8% | $11.93M+0.4% | $11.88M+4.7% | $11.34M+2.0% | $11.13M+46.2% | ||
| -$55.57M+11.4% | -$62.69M-15.5% | -$54.26M+12.5% | -$62.03M-28.0% | -$48.48M+28.4% | ||
| —— | $62K— | $0-100% | $768K-82.2% | $4.32M— | ||
| -$35.35M+87.8% | -$288.63M-1,708% | $17.95M-77.0% | $78.13M+502% | $12.98M— | ||
| $411.17M+9.7% | $374.95M+1,800% | $19.74M+1,573% | $1.18M+89.7% | $622K-98.6% | ||
| $320.25M— | —— | -$16.57M— | —— | -$34.87M-252% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Apogee Therapeutics, Inc. generate?
- Apogee Therapeutics, Inc. (APGE) generated -$234.5M in operating cash flow over the trailing twelve months.
- What is Apogee Therapeutics, Inc.'s free cash flow?
- After $5.1M of capital expenditures, Apogee Therapeutics, Inc.'s free cash flow was -$232.6M over the trailing twelve months, down 35.0% year over year.
- Where does Apogee Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Apogee Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.